Form DEFA14A Strategy Inc
0001050446DEFA14A00010504462025-01-012025-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
(Rule 14a-101)
INFORMATION REQUIRED IN
PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐
Form D Motaris Inc.
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form D Eden X LLC
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 6-K Lufax Holding Ltd For: Oct 16
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2026
Commission File Number 001-39654
Lufax Holding Ltd
(Registrant’s name)
18th Floor, No. 1333
Lujiazui Ring Road
Pudong New District, Shanghai
People’s Republic of China
(Address of principal executive office)
Form D Tuckahoe Holdings, LLC
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
More SEC Filings
View Older Stories-
Form 13F-HR MISHPACHA HOLDINGS CORP For: Sep 30
-
Form 485BXT Investment Managers Seri
-
Form 485BXT Investment Managers Seri
-
Form 485BXT Investment Managers Seri
-
Form 497J Tidal Trust V
-
Form 3 AUTONATION, INC. For: Oct 13 Filed by: Stewart Mark Wynn
-
Form 13F-HR Trium Capital LLP For: Sep 30
-
Form 6-K CORPORACION AMERICA AIRP For: Oct 16
-
Form 8-K AUTONATION, INC. For: Oct 13
-
Form D/A Ancora Impact Fund LP
-
Form 8-K Ladder Capital Corp For: Oct 16
-
Form 8-K MiniMed Group, Inc. For: Oct 15
-
Form 8-K ODYSSEY MARINE EXPLORATI For: Oct 15
-
Form 8-K Blink Charging Co. For: Oct 09
-
Form 8-K/A BRADY CORP For: Aug 03
-
Form 4 MATERION Corp For: Oct 14 Filed by: SHULAR CRAIG S
-
Form AW Tidal Trust IV
-
Form 4 MATERION Corp For: Oct 14 Filed by: Prevost Patrick M.
-
Form 10-K Leopard Energy, Inc. For: Jul 31
-
Form 8-K SMITHFIELD FOODS INC For: Oct 14
-
Form D/A Challenger Trade Finance
-
Form 13F-HR Y-Intercept (Hong Kong) For: Sep 30
-
Form 4 Turbogen Ltd. For: Oct 14 Filed by: KATZ ALEX
-
Form D/A Invesco Real Estate Inco
-
Form D Global Atomic Corp
-
Form NT 10-Q Hestia Insight Inc. For: Aug 31
-
Form 8-K Private Bancorp of Ameri For: Oct 16
-
Form 8-K TOP Financial Group Ltd For: Oct 16
-
Form 8-K ESPEY MFG & ELECTRONICS For: Oct 13
-
Form 497K FRANKLIN TEMPLETON VARIA
-
Form 497 FRANKLIN TEMPLETON VARIA
-
Form 8-K ExxonMobil Holdings Corp For: Oct 16
-
Form DEFA14A CCC Intelligent Solution
-
Form 6-K Immuron Ltd For: Oct 16
-
Form 3/A Turbogen Ltd. For: Aug 28 Filed by: KATZ ALEX
-
Form 1-U Naqi Logix Inc. For: Oct 16
-
Form 8-K Strive, Inc. For: Oct 15
-
Form 4 Uxin Ltd For: Oct 15 Filed by: Dai Kun
-
Form 8-K Strategy Inc For: Oct 15
-
Form D/A Moraine Fund, Ltd
-
Form 13F-NT ASR Nederland N.V. For: Sep 30
-
Form 8-K Ellington Credit Co For: Oct 09
-
Form ARS Actinium Pharmaceuticals For: Dec 31
-
Form 13F-HR ASR Vermogensbeheer N.V. For: Sep 30
-
Form 8-A12B CECO ENVIRONMENTAL CORP
-
Form 8-K Emergent BioSolutions For: Oct 16
-
Form 6-K Nuran Wireless Inc. For: Oct 16
-
Form 497K Eaton Vance Investment
-
Form 497K Eaton Vance Investment
-
Form DEF 14A Actinium Pharmaceuticals For: Nov 25
